Ya who wouldn’t want to miss out on the chance t

Ya who wouldn’t want to miss out on the chance to see Cytodyn, like Red Hat (acquired for $34 billion after a mere $2 billion valuation), Monster Beverage (from $0.50 to $4.6 billion with Coca-Cola), and Juno Therapeutics (jumping from $1 billion to a $9 billion acquisition by Celgene), explode to a billion-dollar valuation just from a sneeze or rumor?

I tend to agree with your stance, however it’s not too far off from reality.

First announce partnership, which would send this into multi billon dollar market cap. Then a year later some data to support a 20 billon dollar offer. IMMU basically 20X in a matter of 8 months I remember because I was invested.

So no we wouldn’t be the first and we won’t be the last.

Daniel Rizzo
Founder & CEO | FireGate Biotech™
AI Platform: Lux Veritas™

Federal Whistleblower Case References
• HHS & SEC Whistleblower ID – HL-1412396
• DOJ Investigation Report / Whistleblower ID – 20250705-0001
• NIH Case Reference – CS1137565 ( IC IG / 50 U.S.C. § 3033 )

Website: FireGateBiotech.com
(For official updates and correspondence — I will no longer be posting here or responding via DMs)

Contact FireGate Biotech


— Jeremiah 51:36